Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berthoux

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Transplantation Proceedings|March 31, 2009
Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 casesW Bichari, M Bartiromo, H Mohey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized StudyR Hellemans, M Hazzan, D Durand, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Transplantation Proceedings|March 15, 2000
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study GroupY Lebranchu, P Aubert, F Bayle, et al.
Transplantation Proceedings|August 1, 1997
An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patientsM Hourmant, C Antoine, F Bayle, et al.
Transplantation|October 2, 2001
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppressionG Mourad, V Garrigue, J P Squifflet, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Transplantation Proceedings|March 31, 2009
Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 casesW Bichari, M Bartiromo, H Mohey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized StudyR Hellemans, M Hazzan, D Durand, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Transplantation Proceedings|March 15, 2000
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study GroupY Lebranchu, P Aubert, F Bayle, et al.
Transplantation Proceedings|August 1, 1997
An open multicenter trial of conversion from Sandimmun to Neoral in stable kidney-transplant patientsM Hourmant, C Antoine, F Bayle, et al.
Transplantation|October 2, 2001
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppressionG Mourad, V Garrigue, J P Squifflet, et al.
Pageof 12